Degli Esposti, L., V. Perrone, D. Sangiorgi, and L. Sinigaglia. “Assessment of Patients Affected by Rheumatoid Arthritis Eligible for Biotechnological Agents and Evaluation of Their Healthcare Resource Utilization and Related Costs”. Reumatismo 73, no. 1 (April 19, 2021): 5–14. Accessed March 29, 2024. https://www.reumatismo.org/reuma/article/view/1329.